Discovery Laboratories (DSCO) 2.52 -0.01

Discovery Laboratories, Inc.
(DSCO) 2.52 -0.01

Last Trade:	2.52	Day Range:	2.49 - 2.57
Trade Time:	08:05PM	52wk Range:	1.441 - 5.39
Prev. Close:	2.53	Market Cap:	109.3M
Open:	2.52	Div Yield:	0
Volume:	217531	PE:	-20
EPS:	-1.09

The Latest On DSCO

Discovery Laboratories Announces Newly-Published Study Compares SURFAXIN LS and CUROSURF in Well-Established Model of Respiratory Distress Syndrome 5/9/12 7:46am

Earnings Scheduled For March 29 3/29/12 3:51am

Discovery Labs Down 17% After Public Offering Announcement 3/16/12 9:43am

Discovery Labs Prices $45.0 Million Public Offering of Common Stock 3/16/12 9:01am

Discovery Labs Announces Proposed Public Offering of Common Stock 3/15/12 4:01pm

Discovery Labs Up 33% After Surfaxin Approved by the FDA 3/7/12 10:44am

Benzinga's Top Pre-Market Gainers 3/7/12 9:23am

US Stock Futures Up Ahead Of ADP Data 3/7/12 7:29am

Stocks To Watch For March 7 3/7/12 4:43am

Discovery Labs Announces FDA Approval of SURFAXIN for Prevention of Respiratory Distress Syndrome 3/6/12 5:11pm

Discovery Labs Signs Manufacturing Agreement for AFECTAIR® 2/8/12 8:45am

Discovery Labs Cleared to Market AFECTAIR in U.S. 2/2/12 8:50am

Discovery Laboratories Announces Newly-Published Study Compares SURFAXIN LS and CUROSURF in Well-Established Model of Respiratory Distress Syndrome 5/9/12

Earnings Scheduled For March 29 3/29/12

Discovery Labs Down 17% After Public Offering Announcement 3/16/12

Discovery Labs Prices $45.0 Million Public Offering of Common Stock 3/16/12

Discovery Labs Announces Proposed Public Offering of Common Stock 3/15/12

Discovery Labs Up 33% After Surfaxin Approved by the FDA 3/7/12

Benzinga's Top Pre-Market Gainers 3/7/12

US Stock Futures Up Ahead Of ADP Data 3/7/12

Stocks To Watch For March 7 3/7/12

Discovery Labs Announces FDA Approval of SURFAXIN for Prevention of Respiratory Distress Syndrome 3/6/12

Discovery Labs Signs Manufacturing Agreement for AFECTAIR® 2/8/12

Discovery Labs Cleared to Market AFECTAIR in U.S. 2/2/12

Stocks To Watch For March 7 3/7/12

Top Percentage Gainers and Losers as of 2pm 5/12/11 (DSCO, OXGN, QCOR, QTWW, SNSS, RPTP, VICL, ORBK, PNSN, SPMD, CLWR, DEXO, CCIH, TNGN, NQ, SYMX, BAC, INTC) 5/12/11

Top Percentage Gainers and Losers as of 2:15pm 05/11/11 (QTWW, OXGN, DSCO, ROVI, IPSU, PEGA, TWER, OWW, M, SMI, IL, STEC, CPTS, KID, CYD, ALTH, WAVX, ALJ, SFUN, RENN) 5/11/11

Trade DSCO
NOW!

Partner Headlines

DSCO: A Biotech Outperformer in Making 5/16/12

Discovery Laboratories (DSCO): The Next Big Small Cap Biotech Stock? CRTX, RMD & ROHI.OB 5/2/12

Discovery Laboratories (DSCO): The Next Big Small Cap Biotech Stocks? CRTX, RMD & ROHI.OB 5/2/12

5 Stocks Under $10 Poised for Upside 4/27/12

Right Time, Right Place: Discovery Laboratories, Inc. (NASDAQ:DSCO) in Focus 4/23/12

For Biotech Takeovers, Timing is Key 4/4/12

Discovery Laboratories Inc. Reports Operating Results (10-K) 3/31/12

For Biotech, 'Fail' is Making a Big Comeback 3/12/12

Investment Newsletters Like These Small Caps, Should You? TransAct Energy (TEGY), Discovery Laboratories (DSCO) & Pressure BioSciences (PBIO) 3/11/12

Biotech Stock Mailbag: Oncothyreon, Amag, Keryx Hate Mail 3/9/12

Press Releases

Newly-Published Study Compares SURFAXIN LS™ and CUROSURF® in Well-Established Model of Respiratory Distress Syndrome 5/9/12 Newswire

Discovery Labs Reports First Quarter 2012 Financial Results 5/3/12 Newswire

Pharmacoeconomic Analysis Shows SURFAXIN® May Reduce Hospital Cost Associated with Reintubation in Premature Infants 5/1/12 Newswire

Discovery Labs to Report First Quarter 2012 Results and Hold Conference Call on Thursday, May 3, 2012 4/26/12 GlobeNewswire

Discovery Labs to Present at the Needham Healthcare Conference 3/29/12 GlobeNewswire

Discovery Labs Reports Fourth Quarter Financial Results and Highlights Recent Milestones 3/29/12 Newswire

Discovery Labs to Report Fourth Quarter 2011 Results and Hold Conference Call on Thursday, March 29, 2012 3/26/12 GlobeNewswire

Discovery Labs Announces Completion of $45.0 Million Public Offering 3/21/12 GlobeNewswire

Discovery Labs Announces Proposed Public Offering of Common Stock 3/15/12 GlobeNewswire

Media Alert: Discovery Labs to Hold Conference Call to Discuss FDA Approval of SURFAXIN® (lucinactant) 3/7/12 Newswire

NEOM, MHYS, SPEX and DSCO are the Daily Market Movers for March 7th from OTCPicks.com 3/7/12 Emailwire

Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome 3/6/12 Newswire

Get the latest DSCO stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Discovery Laboratories, Inc. stock price.

Discovery Laboratories, Inc. by YCharts

Discovery Laboratories (DSCO) 2.52 -0.01

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On DSCO

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social